Steris | STE - Current Liabilities


Steris reported $1.14B in Current Liabilities for its fiscal quarter ending in March of 2026.





Current Liabilities Change Date
3M USD 9.03B 563M Mar/2026
Accuray USD 199.44M 4.83M Dec/2025
Avanos Medical USD 131.2M 34M Mar/2026
Baxter International USD 3.69B 723M Mar/2026
Becton, Dickinson and Co. USD 8.51B 254M Mar/2026
Boston Scientific USD 4.57B 868M Mar/2026
CONMED USD 292.72M 22.32M Mar/2026
Cooper Companies USD 1.6B 482.9M Dec/2025
Dexcom USD 2.22B 81.3M Mar/2026
Ecolab USD 6.1B 561M Mar/2026
Edwards Lifesciences USD 1.41B 404.7M Mar/2026
Fortive USD 2.19B 61.3M Mar/2026
Getinge SEK 15.05B 169M Dec/2024
Globus Medical USD 482.46M 16.04M Mar/2026
Haemonetics USD 282.6M 257.27M Mar/2026
Idexx Laboratories USD 1.3B 151.04M Mar/2026
Inogen USD 64.94M 2.12M Sep/2025
Insulet USD 687.5M 7.4M Mar/2026
Integra LifeSciences USD 346.85M 109.14M Mar/2026
Intuitive Surgical USD 2.51B 3.2M Mar/2026
J&J USD 57.72B 3.59B Mar/2026
Masimo USD 325.4M 46.2M Mar/2026
Olympus JPY 436.87B 36.14B Mar/2026
Orthofix International USD 161.03M 9.45M Mar/2026
Owens Minor USD 1.2B 256.03M Mar/2026
ResMed USD 1.35B 103.1M Mar/2026
Steris USD 1.14B 222.7M Mar/2026
Stryker USD 6.32B 1.48B Mar/2026
Tandem Diabetes Care USD 247.96M 5.24M Mar/2026
Teleflex USD 728.05M 33.98M Mar/2026
Thermo Fisher Scientific USD 14.62B 568M Mar/2026
Zimmer Biomet Holdings USD 2.86B 280.6M Mar/2026